Tuesday’s Biggest Analyst Calls: Nvidia, Microsoft, Tesla, Netflix, Meta, Solaredge & More

Here are Tuesday’s biggest calls on Wall Street:

‍

Goldman Sachs Launches Coverage on Revolution Medicines with a Buy

Goldman Sachs started coverage on Revolution Medicines (RVMD), expressing optimism about the oncology-focused biotech firm. The investment bank assigned a 12-month price target of $65 and highlighted the company’s strong positioning in the cancer treatment space.

‍

Alkermes Also Gets a Buy Rating from Goldman

Goldman also initiated coverage on Alkermes (ALKS) with a Buy rating and a target price of $43. The firm noted Alkermes’ established commercial presence and its portfolio of neuropsychiatric treatments as reasons for its positive stance.

‍

Barclays Begins Coverage on Ralliant with Overweight Rating

Ralliant (RAL) received an Overweight rating from Barclays, which pointed to the company’s high-quality assets and a relatively modest valuation. Barclays described Ralliant as a standout in the multi-industry space, especially given its depressed cycle dynamics affecting sales and margins.

‍

Oppenheimer Reaffirms Outperform Ratings for Nvidia and Broadcom

Oppenheimer reiterated its bullish outlook for both Nvidia (NVDA) and Broadcom (AVGO). The firm raised its price target for Nvidia to $200 (up from $175) and increased Broadcom’s target to $305 (from $265). Oppenheimer also included Marvell Technology (MRVL) and Monolithic Power Systems (MPWR) among its top picks.

‍

JPMorgan Downgrades SolarEdge Technologies

SolarEdge (SEDG) was downgraded by JPMorgan from Overweight to Neutral. The move comes after significant stock appreciation, with analysts noting valuation concerns as the main driver behind the downgrade.

‍

Deutsche Bank Begins Coverage on Jazz Pharmaceuticals with a Buy

Jazz Pharmaceuticals (JAZZ) was initiated with a Buy rating by Deutsche Bank. Analysts described Jazz as a growth-oriented biopharma company with a diversified commercial pipeline. Despite this, the stock is still trading at relatively low valuation multiples compared to peers.

‍

Rosenblatt Launches Coverage on GitLab with Buy Rating

Rosenblatt began coverage on GitLab (GTLB), citing its potential to capture more market share amid the growing complexity of modern cloud infrastructure and generative AI applications. Analysts emphasized GitLab’s strong growth prospects and upselling opportunities.

‍

Nutanix Gets a Buy Rating from Goldman Sachs

Nutanix (NTNX) was also initiated as a Buy by Goldman, which set a price target of $95. The firm sees the software provider as a vital player for companies shifting from legacy systems to modern infrastructure.

‍

Evercore Maintains Neutral View on Tesla

Tesla (TSLA) remains rated as “In Line” at Evercore ISI. The firm warned of mixed signals around the stock, including ongoing earnings estimate cuts, challenges in autonomous vehicle deployment, politically charged messaging, and technical trading indicators.

‍

JPMorgan Upgrades California Resources to Overweight

California Resources (CRC) was upgraded to Overweight from Neutral by JPMorgan. The firm views the stock as undervalued when assessed on a sum-of-the-parts basis.

‍

Wells Fargo Reiterates Microsoft as Overweight, Raises Target

Wells Fargo maintained its Overweight rating on Microsoft (MSFT) and increased its price target to $600 (from $585). Analysts cited strong demand for Microsoft’s AI products and effective cost management, which they believe will drive robust earnings growth next year.

‍

Morgan Stanley Cuts Freeport-McMoRan to Equal Weight

Freeport-McMoRan (FCX) was downgraded from Overweight to Equal Weight. Morgan Stanley noted limited near-term catalysts, though it still sees some upside from the company's exposure to copper and gold prices.

‍

Ameriprise Financial Downgraded by Morgan Stanley

Ameriprise Financial (AMP) was downgraded to Underweight due to slower growth compared to its peers and concerns over its current valuation.

‍

Bank of America Reaffirms Buy Ratings on Netflix, Meta, and Amazon

Bank of America is maintaining a bullish outlook on several tech giants:

• Netflix (NFLX) is expected to meet or exceed guidance for revenue and earnings in Q2 2025.
• Meta Platforms (META) saw its price target raised to $775, with analysts citing the company’s leadership in AI-powered digital advertising.
• Amazon (AMZN) was praised for its successful Prime Day event and efficiency improvements in logistics, including faster delivery via robotics and optimized inventory placement.

‍

Jefferies Downgrades DoorDash

DoorDash (DASH) was lowered to Hold from Buy at Jefferies, citing valuation concerns. The stock has gained 45% year-to-date, and analysts believe much of the company’s strong performance is already priced in.

‍

Southwest Airlines Downgraded by Evercore ISI

Southwest (LUV) was downgraded to In-Line from Outperform due to its strong year-to-date performance and expanded valuation relative to peers.

‍

Bank of America Upgrades National Fuel Gas

National Fuel Gas (NFG) received a two-notch upgrade from Underperform to Buy, with Bank of America raising its price objective to $107, citing an attractive entry point.

‍

Susquehanna Initiates Ryder System with Positive Rating

Ryder (R) was initiated with a Positive rating due to its earnings potential from favorable trucking conditions and capital deployment, despite lacking a valuation re-rating.

‍

Cantor Fitzgerald Launches Coverage on Oklo as Overweight

Oklo, a nuclear energy firm, was rated Overweight by Cantor Fitzgerald, which sees the company leading the transition to nuclear power.

‍

Truist Begins Coverage on Globe Life with Buy Rating

Globe Life (GL) was initiated as a Buy, with analysts highlighting its long-term stability and noting that a short-seller report has created a discount buying opportunity.

‍

American Express Downgraded by Monness Crespi Hardt

American Express (AXP) was downgraded from Buy to Neutral after a 45% surge in the stock. The firm believes the current price already reflects aggressive future earnings assumptions.

‍

‍